Integral Health Asset Management as of March 31, 2025
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 80 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 12.6 | $118M | 1.6M | 76.29 | |
| Boston Scientific Corporation (BSX) | 7.0 | $66M | 650k | 100.88 | |
| Cytokinetics Com New (CYTK) | 4.7 | $44M | 1.1M | 40.19 | |
| Tenet Healthcare Corp Com New (THC) | 3.9 | $37M | 275k | 134.50 | |
| Mineralys Therapeutics (MLYS) | 3.9 | $37M | 2.3M | 15.88 | |
| Anthem (ELV) | 3.0 | $28M | 65k | 434.96 | |
| Novartis Sponsored Adr (NVS) | 3.0 | $28M | 250k | 111.48 | |
| Vera Therapeutics Cl A (VERA) | 2.9 | $28M | 1.2M | 24.02 | |
| Encompass Health Corp (EHC) | 2.9 | $27M | 270k | 101.28 | |
| Medtronic SHS (MDT) | 2.9 | $27M | 300k | 89.86 | |
| Edgewise Therapeutics Call Option (EWTX) | 2.3 | $22M | 975k | 22.00 | |
| Gilead Sciences (GILD) | 2.1 | $20M | 175k | 112.05 | |
| Baxter International (BAX) | 1.8 | $17M | 500k | 34.23 | |
| Fresenius Medical Care Sponsored Adr (FMS) | 1.8 | $17M | 680k | 24.90 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $17M | 150k | 110.60 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.7 | $16M | 100k | 155.86 | |
| Brightspring Health Svcs (BTSG) | 1.5 | $14M | 775k | 18.09 | |
| CVS Caremark Corporation (CVS) | 1.4 | $14M | 200k | 67.75 | |
| Alnylam Pharmaceuticals (ALNY) | 1.4 | $14M | 50k | 270.02 | |
| Uniqure Nv SHS (QURE) | 1.4 | $13M | 1.3M | 10.60 | |
| Arcellx Common Stock Call Option (ACLX) | 1.4 | $13M | 200k | 65.60 | |
| Blueprint Medicines (BPMC) | 1.4 | $13M | 145k | 88.51 | |
| Abbvie (ABBV) | 1.3 | $13M | 60k | 209.52 | |
| RadNet (RDNT) | 1.3 | $12M | 250k | 49.72 | |
| Ge Healthcare Technologies I Common Stock (GEHC) | 1.3 | $12M | 150k | 80.71 | |
| Krystal Biotech (KRYS) | 1.2 | $11M | 60k | 180.30 | |
| Inspire Med Sys (INSP) | 1.1 | $10M | 65k | 159.28 | |
| Tarsus Pharmaceuticals (TARS) | 1.1 | $10M | 200k | 51.37 | |
| Penumbra (PEN) | 1.0 | $9.4M | 35k | 267.41 | |
| Edwards Lifesciences (EW) | 1.0 | $9.1M | 125k | 72.48 | |
| Revolution Medicines (RVMD) | 0.9 | $8.8M | 250k | 35.36 | |
| McKesson Corporation (MCK) | 0.9 | $8.1M | 12k | 672.99 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.8 | $7.8M | 200k | 39.07 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.8 | $7.7M | 500k | 15.37 | |
| 89bio (ETNB) | 0.8 | $7.6M | 1.1M | 7.27 | |
| Pfizer (PFE) | 0.8 | $7.6M | 300k | 25.34 | |
| Acadia Healthcare (ACHC) | 0.8 | $7.6M | 250k | 30.32 | |
| Masimo Corporation (MASI) | 0.8 | $7.5M | 45k | 166.60 | |
| Waters Corporation (WAT) | 0.8 | $7.4M | 20k | 368.57 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.8 | $7.3M | 115k | 63.49 | |
| Dex (DXCM) | 0.7 | $6.8M | 100k | 68.29 | |
| Xenon Pharmaceuticals Put Option (XENE) | 0.7 | $6.7M | 200k | 33.55 | |
| Regenxbio Inc equity us cm (RGNX) | 0.7 | $6.6M | 925k | 7.15 | |
| Bristol Myers Squibb (BMY) | 0.6 | $6.1M | 100k | 60.99 | |
| Roivant Sciences SHS (ROIV) | 0.6 | $6.1M | 600k | 10.09 | |
| Protara Therapeutics Com Stk (TARA) | 0.6 | $6.0M | 1.4M | 4.26 | |
| Avidity Biosciences Ord Put Option (RNA) | 0.6 | $5.9M | 200k | 29.52 | |
| Iqvia Holdings (IQV) | 0.6 | $5.3M | 30k | 176.30 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.5 | $5.1M | 150k | 34.03 | |
| Ptc Therapeutics I (PTCT) | 0.5 | $5.1M | 100k | 50.96 | |
| Alkermes SHS (ALKS) | 0.5 | $5.0M | 150k | 33.02 | |
| Viking Therapeutics Call Option (VKTX) | 0.5 | $4.8M | 200k | 24.15 | |
| Dyne Therapeutics (DYN) | 0.5 | $4.7M | 450k | 10.46 | |
| Labcorp Holdings Com Shs (LH) | 0.5 | $4.7M | 20k | 232.74 | |
| Becton, Dickinson and (BDX) | 0.5 | $4.6M | 20k | 229.06 | |
| Biohaven (BHVN) | 0.4 | $4.2M | 175k | 24.04 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.4 | $4.2M | 125k | 33.54 | |
| Scholar Rock Hldg Corp (SRRK) | 0.4 | $4.0M | 125k | 32.15 | |
| Alignment Healthcare (ALHC) | 0.4 | $3.7M | 200k | 18.62 | |
| Globus Med Cl A (GMED) | 0.4 | $3.7M | 50k | 73.20 | |
| Biontech Se Sponsored Ads (BNTX) | 0.4 | $3.6M | 40k | 91.06 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.4 | $3.6M | 150k | 24.25 | |
| Bridgebio Pharma (BBIO) | 0.4 | $3.5M | 100k | 34.57 | |
| Sana Biotechnology (SANA) | 0.4 | $3.4M | 2.0M | 1.68 | |
| Cigna Corp (CI) | 0.4 | $3.3M | 10k | 329.00 | |
| Nurix Therapeutics (NRIX) | 0.3 | $3.3M | 275k | 11.88 | |
| Verastem Com New (VSTM) | 0.3 | $3.0M | 500k | 6.03 | |
| Oscar Health Cl A (OSCR) | 0.3 | $2.6M | 200k | 13.11 | |
| Repligen Corporation (RGEN) | 0.3 | $2.5M | 20k | 127.24 | |
| Jasper Therapeutics Com New (JSPR) | 0.3 | $2.5M | 575k | 4.30 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.2 | $2.2M | 175k | 12.74 | |
| Atyr Pharma Com New (ATYR) | 0.2 | $2.1M | 700k | 3.02 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $1.9M | 700k | 2.76 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.2 | $1.8M | 800k | 2.25 | |
| Rezolute Com New (RZLT) | 0.2 | $1.5M | 500k | 2.90 | |
| Cabaletta Bio (CABA) | 0.1 | $1.2M | 850k | 1.39 | |
| Tenax Therapeutics Com New (TENX) | 0.1 | $1.1M | 167k | 6.55 | |
| Alto Neuroscience Com Shs (ANRO) | 0.1 | $864k | 400k | 2.16 | |
| Palatin Technologies Com New (PTNT) | 0.1 | $583k | 1.0M | 0.58 | |
| Fate Therapeutics (FATE) | 0.1 | $553k | 700k | 0.79 |
